RIMTERAVIMAB

UNII:	Z4LZB5VCU4
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	RIMTERAVIMAB
GSRS Full Record:	Z4LZB5VCU4 i

2540797-21-3
IMMUNOGLOBULIN GAMMA1 VH-H-CH2-CH3 DIMER, ANTI-(RECEPTOR BINDING DOMAIN (RBD) OF THE SPIKE (S)GLYCOPROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROMECORONAVIRUS (SARS-COV) / SEVERE ACUTE RESPIRATORYSYNDROME CORONAVIRUS 2 (SARS-COV-2) / BAT SARSLIKE(BAT) CORONAVIRUS WIV1 (BAT SL-COV-WIV1)), MONOCLONAL ANTIBODY, BIVALENT
XVR 011 [WHO-DD]
rimteravimab [INN]

Common Chemistry
i
Inxight Drugs
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RIMTERAVIMAB

Synonyms and Mappings

Resources